Study on the therapeutic effect and some immune factors by methotrexate modified superparamagnetic nanoparticles in rat mammary tumors†

IF 4.6 3区 材料科学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Li Huang, Xing Zhao, Jun Zhang, Jiquan Zhang, Weike Liao, Yanhua Fan, Jintian Tang, Zhixu He, Fuping Gao and Weiwei Ouyang
{"title":"Study on the therapeutic effect and some immune factors by methotrexate modified superparamagnetic nanoparticles in rat mammary tumors†","authors":"Li Huang, Xing Zhao, Jun Zhang, Jiquan Zhang, Weike Liao, Yanhua Fan, Jintian Tang, Zhixu He, Fuping Gao and Weiwei Ouyang","doi":"10.1039/D4NA00295D","DOIUrl":null,"url":null,"abstract":"<p >\r\n <em>Objective</em>: this study investigates the efficacy, immunological impact, and preliminary safety of methotrexate (MTX) modified magnetic Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles in thermochemotherapy for mammary tumors in rats. <em>Methods</em>: transmission electron microscopy images revealed that the MTX-modified magnetic Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles are nearly spherical, approximately 10 nm in diameter. Chemically co-precipitated PEI-modified magnetic nanoparticles were utilized for thermotherapy, while MTX-modified nanoparticles were employed for thermochemotherapy. These nanoparticles were locally injected into the Walker-256 tumor tissues of Wistar rats. The experimental design included twelve groups, encompassing various protocols of thermotherapy and thermochemotherapy at 47 °C and 42 °C, a group receiving only MTX nanoparticle chemotherapy, and several control groups. The biodistribution of residual magnetic nanoparticles was assessed in vital organs such as the heart, liver, lungs, kidneys, and brain. <em>Results</em>: demonstrated that these magnetic nanoparticles primarily accumulated in the tumor's central region and were unevenly distributed at the margins. The nanoparticles were capable of penetrating tumor cells but were more dispersed around them. Importantly, no residual magnetic nanoparticles were detected in vital organs. Significant tumor reduction and prolonged survival times were observed in the 47 °C thermochemotherapy group, the 47 °C thermotherapy group and the repeated 42 °C thermochemotherapy group. Additionally, significant increases in IL-2 and IFN-γ levels, along with a decrease in IL-4 levels, were detected in the 47 °C thermochemotherapy and 47 °C thermotherapy groups. <em>Conclusion</em>: MTX-modified Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> magnetic nanoparticles demonstrate potential as an effective medium for thermochemotherapy. They are safe, tolerable, contribute to prolonged survival, and enhance immune functions in tumor-bearing rats without leaving residues in vital organs. These results provide a promising foundation for future cancer treatment research.</p>","PeriodicalId":18806,"journal":{"name":"Nanoscale Advances","volume":" 2","pages":" 601-613"},"PeriodicalIF":4.6000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622858/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanoscale Advances","FirstCategoryId":"88","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/na/d4na00295d","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: this study investigates the efficacy, immunological impact, and preliminary safety of methotrexate (MTX) modified magnetic Fe3O4 nanoparticles in thermochemotherapy for mammary tumors in rats. Methods: transmission electron microscopy images revealed that the MTX-modified magnetic Fe3O4 nanoparticles are nearly spherical, approximately 10 nm in diameter. Chemically co-precipitated PEI-modified magnetic nanoparticles were utilized for thermotherapy, while MTX-modified nanoparticles were employed for thermochemotherapy. These nanoparticles were locally injected into the Walker-256 tumor tissues of Wistar rats. The experimental design included twelve groups, encompassing various protocols of thermotherapy and thermochemotherapy at 47 °C and 42 °C, a group receiving only MTX nanoparticle chemotherapy, and several control groups. The biodistribution of residual magnetic nanoparticles was assessed in vital organs such as the heart, liver, lungs, kidneys, and brain. Results: demonstrated that these magnetic nanoparticles primarily accumulated in the tumor's central region and were unevenly distributed at the margins. The nanoparticles were capable of penetrating tumor cells but were more dispersed around them. Importantly, no residual magnetic nanoparticles were detected in vital organs. Significant tumor reduction and prolonged survival times were observed in the 47 °C thermochemotherapy group, the 47 °C thermotherapy group and the repeated 42 °C thermochemotherapy group. Additionally, significant increases in IL-2 and IFN-γ levels, along with a decrease in IL-4 levels, were detected in the 47 °C thermochemotherapy and 47 °C thermotherapy groups. Conclusion: MTX-modified Fe3O4 magnetic nanoparticles demonstrate potential as an effective medium for thermochemotherapy. They are safe, tolerable, contribute to prolonged survival, and enhance immune functions in tumor-bearing rats without leaving residues in vital organs. These results provide a promising foundation for future cancer treatment research.

Abstract Image

甲氨蝶呤修饰的超顺磁性纳米颗粒对大鼠乳腺肿瘤的治疗效果及部分免疫因子的研究。
目的:本研究探讨了甲氨蝶呤(MTX)修饰的磁性 Fe3O4 纳米粒子在大鼠乳腺肿瘤热化疗中的疗效、免疫学影响和初步安全性。方法:透射电子显微镜图像显示,MTX 修饰的磁性 Fe3O4 纳米粒子接近球形,直径约为 10 纳米。化学共沉淀 PEI 改性磁性纳米粒子用于热疗,而 MTX 改性纳米粒子用于热化学疗法。这些纳米粒子被局部注射到 Wistar 大鼠的 Walker-256 肿瘤组织中。实验设计包括十二个组,包括 47 ℃ 和 42 ℃ 下的各种热疗和热化疗方案,一个仅接受 MTX 纳米粒子化疗的组,以及几个对照组。评估了残留磁性纳米粒子在心脏、肝脏、肺部、肾脏和大脑等重要器官的生物分布情况。结果表明:这些磁性纳米粒子主要积聚在肿瘤中心区域,在肿瘤边缘分布不均。纳米粒子能够穿透肿瘤细胞,但更多地分散在肿瘤细胞周围。重要的是,在重要器官中没有检测到残留的磁性纳米粒子。47 °C热化疗组、47 °C热化疗组和重复42 °C热化疗组均观察到肿瘤明显缩小,生存时间延长。此外,47 ℃热化疗组和 47 ℃热化疗组的 IL-2 和 IFN-γ 水平明显升高,IL-4 水平下降。结论MTX修饰的Fe3O4磁性纳米粒子具有作为热化疗有效介质的潜力。它们安全、可耐受、有助于延长肿瘤大鼠的生存期并增强其免疫功能,且不会在重要器官中留下残留物。这些结果为未来的癌症治疗研究奠定了良好的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nanoscale Advances
Nanoscale Advances Multiple-
CiteScore
8.00
自引率
2.10%
发文量
461
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信